Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension.
Catherine M AvitabileXuemei ZhangSteve B AmpahYan WangDevon AshKathleen NilanLaura Mercer-RosaJulie L FierroDavid B FrankKathleen A GibbsPublished in: Journal of perinatology : official journal of the California Perinatal Association (2022)
In BPD-PH, childhood discontinuation of pulmonary vasodilator therapy is associated with markers of disease severity.